Peptide-mediated cellular delivery of antisense oligonucleotides and their analogues

被引:0
|
作者
Michael J. Gait
机构
[1] Medical Research Council,
[2] Laboratory of Molecular Biology,undefined
[3] Hills Road,undefined
[4] Cambridge CB2 2QH (United Kingdom),undefined
[5] Fax: +44 1223 402070,undefined
[6] e-mail: mgait@mrc-lmb.cam.ac.uk ,undefined
关键词
Key words: Antisense; conjugates; oligonucleotides; peptides; PNA.;
D O I
暂无
中图分类号
学科分类号
摘要
Improving the delivery of synthetic oligonucleotides and their analogues into cells is an important goal in the full development of antisense technology for control of gene expression in cell culture and in vivo. This review describes the harnessing of certain peptides, either as noncovalent complexes or as covalent conjugates, to enhance the delivery of antisense oligonucleotides into cells and/or to affect their cell localization. Phosphodiester and phosphorothioate oligonucleotides are included as well as peptide nucleic acids (PNAs), analogues of oligonucleotides where the negatively charged phosphate backbone is replaced by a neutral amide linkage. This review contains a critical evaluation of claims for certain peptide-oligonucleotide conjugates to translocate into cultured cells by a non-energy-dependent nonendosomal route. In addition, the available evidence for the utility of stable versus nonstable linkages between peptide and oligonucleotide or PNA is discussed.
引用
收藏
页码:844 / 853
页数:9
相关论文
共 50 条
  • [1] Peptide-mediated cellular delivery of antisense oligonucleotides and their analogues
    Gait, MJ
    CELLULAR AND MOLECULAR LIFE SCIENCES, 2003, 60 (05) : 844 - 853
  • [2] Peptide-mediated delivery of antisense oligonucleotides and related material
    Vivès, E
    Richard, JP
    Lebleu, B
    NUCLEIC ACID THERAPEUTICS IN CANCER, 2004, : 115 - 127
  • [3] Peptide-mediated Cell and In Vivo Delivery of Antisense Oligonucleotides and siRNA
    Jaerver, Peter
    Coursindel, Thibault
    Andaloussi, Samir E. L.
    Godfrey, Caroline
    Wood, Matthew J. A.
    Gait, Michael J.
    MOLECULAR THERAPY-NUCLEIC ACIDS, 2012, 1
  • [4] Peptide-mediated cellular delivery
    Schwartz, JJ
    Zhang, SG
    CURRENT OPINION IN MOLECULAR THERAPEUTICS, 2000, 2 (02) : 162 - 167
  • [5] Conjugation Approaches for Peptide-Mediated Delivery of Oligonucleotides Therapeutics
    Patil, Nitin A.
    AUSTRALIAN JOURNAL OF CHEMISTRY, 2022, 75 (02) : 24 - 33
  • [6] Peptide-mediated cellular delivery of semiconductor quantum dots
    Gemmill, Kelly Boeneman
    Muttenthaler, Markus
    Delehanty, James
    Deschamps, Jeff
    Susumu, Kimihiro
    Stewart, Michael
    Dawson, Philip
    Huston, Alan
    Medintz, Igor
    SENSING TECHNOLOGIES FOR GLOBAL HEALTH, MILITARY MEDICINE, AND ENVIRONMENTAL MONITORING III, 2013, 8723
  • [7] Tat peptide-mediated cellular delivery:: back to basics
    Brooks, H
    Lebleu, B
    Vivès, E
    ADVANCED DRUG DELIVERY REVIEWS, 2005, 57 (04) : 559 - 577
  • [8] Cellular delivery of antisense oligonucleotides
    Lebedeva, I
    Benimetskaya, L
    Stein, CA
    Vilenchik, M
    EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2000, 50 (01) : 101 - 119
  • [9] The cellular delivery of antisense oligonucleotides and ribozymes
    Hughes, MD
    Hussain, M
    Nawaz, Q
    Sayyed, P
    Akhtar, S
    DRUG DISCOVERY TODAY, 2001, 6 (06) : 303 - 315
  • [10] Optimized luciferase assay for cell-penetrating peptide-mediated delivery of short oligonucleotides
    Helmfors, Henrik
    Eriksson, Jonas
    Langel, Ulo
    ANALYTICAL BIOCHEMISTRY, 2015, 484 : 136 - 142